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OBJECTIVES The purpose of this study was to determine the characteristics and outcomes of patients with
acute myocardial infarction (MI) complicated by cardiogenic shock due to predominant right
ventricular (RV) infarction.
BACKGROUND Although RV infarction has been shown to have favorable long-term outcomes, the influence
of RV infarction on mortality in cardiogenic shock is unknown.
METHODS We evaluated 933 patients in cardiogenic shock due to predominant RV (n  49) or left
ventricular (LV) failure (n  884) in the SHould we emergently revascularize Occluded
coronaries for Cardiogenic shocK? (SHOCK) trial registry.
RESULTS Patients with predominant RV shock were younger, with a lower prevalence of previous MI
(25.5 vs. 40.1%, p  0.047), anterior MI, and multivessel disease (34.8 vs. 77.8%, p  0.001)
and a shorter median time between the index MI and the diagnosis of shock (2.9 vs. 6.2 h,
p  0.003) in comparison to patients with LV shock. In-hospital mortality was 53.1% versus
60.8% (p  0.296) for patients with predominant RV and LV shock, respectively, and the
influence of revascularization on mortality was not different between groups. Multivariate
analysis revealed that RV shock was not an independent predictor of lower in-hospital
mortality (odds ratio 1.07, 95% confidence interval 0.54 to 2.13).
CONCLUSIONS Despite the younger age, lower rate of anterior MI, and higher prevalence of single-vessel
coronary disease of RV compared with LV shock patients, and their similar benefit from
revascularization, mortality is unexpectedly high in patients with predominant RV shock and
similar to patients with LV shock. (J Am Coll Cardiol 2003;41:1273–9) © 2003 by the
American College of Cardiology Foundation
Despite more recent aggressive reperfusion and revascular-
ization strategies, patients with myocardial infarction (MI)
complicated by cardiogenic shock continue to have a rela-
tively poor prognosis (1,2). The majority of patients with
this condition have severe left ventricular (LV) dysfunction
See page 1280
secondary to acute MI underlying their clinical presentation
(3). However, a small subset of patients in shock has
significant right ventricular (RV) dysfunction in isolation or
in combination with LV dysfunction (1,3). Although RV
infarction, which complicates acute inferior MI in approx-
imately 50% of patients (4), has been thought to have a
favorable long-term prognosis (5,6), some series report a
significant increase in early mortality in patients with acute
inferior MI and RV involvement (7). However, few data are
available describing the influence of RV infarction on
mortality for patients in cardiogenic shock. Accordingly, to
determine the characteristics and outcomes of patients with
acute MI complicated by cardiogenic shock due to RV
infarction, we compared patients in shock with predominant
RV and LV dysfunction in a large registry associated with
the SHould we emergently revascularize Occluded coro-
naries for Cardiogenic shocK? (SHOCK) trial.
METHODS
SHOCK trial registry. The SHOCK trial was a random-
ized comparison of early percutaneous or surgical revascu-
larization versus initial medical stabilization (including
thrombolytic therapy and intra-aortic balloon counterpulsa-
tion, where appropriate) for patients with acute MI com-
plicated by cardiogenic shock (2). Patients with suspected
cardiogenic shock either ineligible for participation or eli-
gible but not randomized were entered into a registry which
began in April 1993 and ended enrollment in August 1997.
Additional screening of 188 patients from September 1997
to November 1998 identified nine additional RV shock
patients. A local discharge diagnosis of acute MI plus
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cardiogenic shock (diagnosis-related group 410 and 785.51)
constituted criteria for entering the registry. Patients were
enrolled from 36 centers, initiated in staggered fashion,
including 24 centers in the U.S. (n  576, 62%), 5 centers
in Canada (n  197, 21%), 4 centers in Belgium (n  54,
6%), and 1 center each in Australia, New Zealand, and
Brazil (n  106, 11%). The institutional committee on
human research approved the study protocol at each center.
Patient sample. This report is based on 933 patients with
cardiogenic shock due to predominant RV failure or primary
LV failure, a subset of the 1,378 patients with cardiogenic
shock complicating acute MI who were prospectively reg-
istered. The study group included 49 patients (5.3%) with
predominant RV failure and 884 patients (94.7%) with
predominant LV failure.
Definitions. “Isolated” RV shock was an exclusion for
enrollment into the randomized trial and was assessed at
each participating site on the basis of available data, which
included clinical, electrocardiographic (ECG), hemody-
namic, and echocardiographic findings. Predominant LV
failure was designated as the etiology of cardiogenic shock
when none of the following major shock categories was
indicated: isolated RV shock, mechanical cause, tamponade,
previous severe valvular heart disease, shock resulting from a
cardiac catheterization laboratory complication, excess phar-
macologic therapy, or noncardiac cause. Creatine kinase
(CK) values reported are the highest recorded (based on
three or more measures in 71.3% of patients). The ECG
location of the infarct was defined as follows (8): V1 through
V4 anterior; II, III, aVF inferior; V5, V6 apical; I, AVL
lateral; V1, V2 posterior.
Data collection. Data were abstracted from the medical
record by the SHOCK study coordinators, who were
centrally trained to complete standard study report forms.
Patient characteristics, MI characteristics, hemodynamics,
procedure use, and vital status at discharge were recorded.
Cardiac catheterization and angioplasty reports were sent to
the Clinical Coordinating Center for abstraction and com-
pletion of the standard form. Of the 49 patients with
predominant RV shock, 31 underwent coronary angiogra-
phy and 23 angiograms were obtained for review by two
independent angiographers.
Statistical analysis. All analyses compared a group of 49
patients with predominant RV shock to a group of 884
patients with primary LV shock complicating MI. The
distributions of demographic, clinical, angiographic, and
treatment variables were compared. Fisher exact test was
used to compare the distribution of unordered categorical
factors. Student t test was used to compare the means of
normally distributed variables, and the Wilcoxon test was
used to compare the distributions of ordinal and non-
normally distributed variables. The Mantel-Haenszel test
for linear trend (9) was used to compare the distribution of
the number of diseased vessels for the two groups. Logistic
regression was used to determine whether RV shock was an
independent risk factor for in-hospital mortality. Kaplan-
Meier estimates of in-hospital survival were used for the
survival figure, and the log-rank test was used to compare
survival distributions. All hypothesis testing was two-sided,
and a p value 0.05 was considered significant. All statis-
tical analyses were conducted using the Statistical Analysis
System (version 6.12, SAS Institute Inc., Cary, North
Carolina) and S-Plus for Windows (Statistical Sciences
Inc., Seattle, Washington).
RESULTS
Clinical characteristics. Patients with predominant RV
shock were younger than patients with LV shock, although
coronary artery disease risk factor profile, with the exception
of hyperlipidemia, was similar between the two groups
(Table 1). There was a lower incidence of previous MI for
patients with predominant RV shock, although the preva-
lence of other comorbid conditions such as renal insuffi-
ciency, peripheral vascular disease, and previous revascular-
ization was similar to that in patients with LV shock.
Characteristics and location of the infarct. Although the
proportion of patients transferred from other hospitals to
the SHOCK registry site was similar in the two groups, the
median time between the index MI and the diagnosis of
shock was shorter in patients with predominant RV shock
in comparison to patients with LV shock (2.9 vs. 6.2 h, p 
0.003). There was no difference in the median highest total
Abbreviations and Acronyms
CK  creatine kinase
ECG  electrocardiographic
LAD  left anterior descending coronary artery
LV  left ventricular
MI  myocardial infarction
RCA  right coronary artery
RV  right ventricular
SHOCK  SHould we emergently revascularize
Occluded coronaries for Cardiogenic shocK?
Table 1. Clinical Characteristics
RV Shock
(n  49)
LV Shock
(n  884) p Value
Mean age (yrs) 64.5  12.0 68.5  12.1 0.031
Age 75 yrs (%) 81.6 67.5 0.041
Male (%) 53.1 63.6 0.171
Hypertension (%) 52.2 51.7 1.00
Diabetes (%) 30.4 32.8 0.872
Smoking (%) 46.2 51.5 0.623
Elevated lipids (%) 66.7 40.2 0.022
Previous MI (%) 25.5 40.1 0.047
Congestive heart failure (%) 11.1 19.8 0.178
Renal insufficiency (%) 11.1 10.7 0.809
Peripheral vascular disease (%) 11.1 18.8 0.447
Previous CABG (%) 2.1 10.1 0.077
Previous PTCA (%) 6.5 6.7 1.00
CABG  coronary artery bypass graft surgery; LV  left ventricular; MI 
myocardial infarcton; PTCA  percutaneous transluminal coronary angioplasty; RV
 right ventricular.
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CK level between groups. Patients with predominant RV
shock were treated with thrombolytic therapy more often
than were patients with LV shock (51.1% vs. 34.4%, p 
0.021). As expected, very few patients with predominant
RV shock had an anterior MI (10.6%) in contrast to high
rates for patients with LV shock (Table 2). Most patients
with predominant RV shock had an inferior or posterior
MI. Of note, LV ejection fraction, available in 34% of
patients, was significantly higher in patients with predom-
inant RV shock compared with LV shock (41.9%  15.7%
vs. 30.0%  12.6%, p  0.002).
Hemodynamic characteristics. Right heart catheterization
was performed in just over 60% of patients at a median time
of 3.3 (1.0, 7.6) h after the onset of shock (Table 3). Of
note, 96% of patients were treated with vasopressors (pre-
dominant RV shock, n  34, 100% vs. LV shock, n  633,
95.7%, p  0.390) and 70.6% were treated with inotropes
(predominant RV shock, n  34, 55.9% vs. LV shock, n 
633, 71.4%, p  0.080). Right atrial pressure was signifi-
cantly higher and systolic pulmonary artery pressure signif-
icantly lower in patients with predominant RV shock,
although mean pulmonary capillary wedge pressure, cardiac
output, and cardiac index were similar in the two groups.
Furthermore, there was no difference in systolic blood
pressure (88 23 vs. 88 23 mm Hg, p 0.456), diastolic
blood pressure (52  15 vs. 53  17 mm Hg, p  0.314),
or lowest systolic blood pressure recorded (69 18 vs. 68
16 mm Hg, p  0.819) in the two groups, although heart
rate (85.4 25.7 vs. 95.2 25.8 beats/min, p 0.042) was
lower in patients with predominant RV shock in compari-
son to LV shock.
Angiographic characteristics. As expected, in the subset
of patients undergoing coronary angiography (Table 4), the
right coronary artery (RCA) was more likely to be the
infarct artery in patients with predominant RV shock and
the left anterior descending artery (LAD) was more likely to
be the infarct-related artery in patients with LV shock. In
addition, patients with predominant RV shock were more
likely to have single- and double-vessel disease and less likely to
have triple-vessel disease than patients with LV shock.
Table 2. Characteristics and Location of the Infarct
RV Shock
(n  49)
LV Shock
(n  884) p Value
Transfer admission (%) 36.7 43.2 0.459
MI to shock (h)* 2.9 6.2 0.003
Highest total CPK (U/l)* 2,359 1,940 0.795
CPK/ULN* 14.7 8.9 0.201
Thrombolytic therapy (%) 51.0 34.4 0.021
ECG location
Anterior (%) 10.6 58.8  0.0001
Inferior (%) 85.1 34.4  0.0001
Posterior (%) 40.4 17.3  0.001
Lateral (%) 23.4 31.9 0.259
Apical (%) 6.4 9.6 0.612
Multiple locations (%) 55.3 48.4 0.372
n  17 n  300
LV ejection fraction post shock (%)† 41.9  15.7 30.0  12.6 0.002
*Median; †LV function measured using echocardiography 59%, LV angiography 36%, radionuclide ventriculography 5%.
CPK  creatine phosphokinase; ECG  electrocardiographic; LV  left ventricular; MI  myocardial infarction; RV 
right ventricular; ULN  upper limit of normal.
Table 3. Hemodynamic Characteristics*
RV Shock LV Shock p Value
Right heart catheterization (%) 61.2 64.4 0.649
n  49,884
Right atrial pressure (mm Hg) 23.0  9.9 14.2  7.4 0.0001
n  17,276
Systolic pulmonary artery pressure (mm Hg) 35.0  7.3 41.1  12.8 0.045
n  21,341
Diastolic pulmonary artery pressure (mm Hg) 22.2  6.3 23.9  8.0 0.370
n  21,343
Pulmonary capillary wedge pressure (mm Hg) 23.1  11.2 23.6  8.6 0.339
n  30,534
Cardiac output (l/min) n  16,282 3.8  1.6 3.9  1.6 0.774
Cardiac index (l/min/m2) n  16,408 1.9  0.6 2.1  0.8 0.776
Right atrial/pulmonary capillary wedge pressure 0.8 (%) 70.6 23.6 0.0001
n  17,275
*Measurements obtained on sympathomimetic amines and/or intra-aortic balloon support.
LV  left ventricular; RV  right ventricular.
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In-hospital treatment. There was no difference in the use
of intra-aortic balloon counterpulsation (49.0 vs. 52.6%,
p  0.661) between patients with predominant RV and
LV shock, respectively. However, patients with pre-
dominant RV shock were more likely to be treated with
coronary angioplasty (49.0 vs. 32.8%, p  0.029). Rates of
coronary bypass surgery (10.2 vs. 15.4%, p  0.415) were
similar.
In-hospital outcomes. The incidence of reinfarction (8.8
vs. 8.1%, p 0.751) and recurrent ischemia (12.1 vs. 18.9%,
p  0.490) were similar for the two groups. Of note,
in-hospital mortality was 53.1% for patients with predom-
inant RV shock and 60.8% in patients with LV shock, p 
0.296 (Fig. 1). Multivariate analysis of in-hospital mortality,
with adjustment for age, the time between the index
infarction to the onset of cardiogenic shock, coronary
angioplasty, thrombolytic therapy, and anterior MI revealed
that predominant RV shock was not an independent pre-
dictor of in-hospital death (odds ratio 1.07, 95% confidence
interval 0.54 to 2.13). The Kaplan-Meier estimates of
in-hospital survival for patients with predominant RV and
LV shock are shown in Figure 2.
In-hospital revascularization. The influence of revascu-
larization on mortality for patients with predominant
RV and LV shock is depicted in Figure 3. Mortality for
patients undergoing coronary angioplasty, coronary bypass
surgery, or any revascularization procedure was not different
in the two groups. Although mortality was higher for
patients not selected for revascularization, there was no
statistical difference in in-hospital mortality (65.2 vs. 78.3%,
p  0.195) in those patients with predominant RV and LV
shock.
DISCUSSION
Clinical characteristics. The striking finding of this study
is the similarly poor outcomes despite the younger age and
different infarct location in patients with predominant RV
shock compared with LV shock. Previous studies have
noted a more favorable prognosis for patients with inferior
MI in comparison to anterior MI (10,11). This observation
may extend to patients with predominant RV shock where
the degree of LV dysfunction is usually less than with LV
shock. Therefore, it is disappointing that patients with
predominant RV shock had a similar in-hospital mortality
to patients with LV shock despite their seemingly lower risk
profile, suggesting that the hemodynamic consequences of
RV shock significantly impact early mortality.
Right ventricular infarction has been recognized as a
clinical syndrome (12,13) and, as such, the diagnosis of
predominant RV shock was made using clinical and non-
invasive findings at each site. The hemodynamic data, high
incidence of the right coronary as the infarct artery, and
relatively preserved LV function serve to confirm the accu-
rate diagnosis in this study.
Hemodynamic characteristics. The severity of the hemo-
dynamic abnormalities associated with RV infarction is
related to the extent of RV ischemia and consequent RV
dysfunction as well as to the restraining effect of the
Table 4. Angiographic Characteristics
RV
Shock
LV
Shock p Value
Infarct-related artery (%) n  23 n  417  0.001
Left anterior descending 0.0 44.1
Left circumflex 0.0 14.2
Right coronary 95.7 27.1
Left main 4.3 6.7
Saphenous vein graft 0.0 7.9
Number of vessels diseased (%) n  23 n  518  0.001
One 65.2 22.2
Two 30.4 20.7
Three 4.4 57.1
Left main (%) 8.0 16.3 0.402
LV  left ventricular; RV  right ventricular.
Figure 1. In-hospital outcomes in patients with predominant right ventricular (RV) and left ventricular (LV) shock.
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pericardium (14), LV function, and ventricular interdepen-
dence. It has now been shown both experimentally (15) and
clinically (16) that the intact LV may assist RV ejection by
LV septal contraction causing a bulging into the RV which
generates an active RV systolic pressure wave and systolic
force sufficient for pulmonary perfusion. Loss of this mech-
anism with concomitant LV infarction, particularly when
the interventricular septum is involved, may lead to further
hemodynamic deterioration in patients with RV infarction.
Furthermore, augmented atrial contraction is necessary to
overcome the stiffness of the ischemic RV, and factors that
impair RV filling (intravascular volume depletion, concom-
itant atrial infarction, loss of atrioventricular synchrony)
may severely compromise hemodynamics and result in
cardiogenic shock. In the present study, it was expected that
right atrial pressure would be significantly higher (although
a right atrial pressure of 23 mm Hg suggests excess volume
loading) and pulmonary artery pressure significantly lower
in patients with predominant RV shock in comparison to
LV shock. The similarity in pulmonary capillary wedge
pressure is noteworthy. It is consistent with the systemic
hypotension and LV dysfunction that occurs even when RV
infarction is responsible for shock and supports previous
reports noting that the hemodynamic consequence of RV
dysfunction is the result of a critical interaction between
both ventricles with interventricular septal shift into the LV
Figure 2. In-hospital survival curves for patients with predominant right ventricular (RV) and left ventricular (LV) shock truncated at 50 days. In-hospital
survival rates were 46.9% for patients with predominant RV shock and 39.2% for patients with LV shock.
Figure 3. Mortality for patients with predominant right ventricular (RV) and left ventricular (LV) shock undergoing coronary artery bypass graft surgery
(CABG) and percutaneous transluminal coronary angioplasty (PTCA).
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(17). In comparison to the LV, the RV is poorly adapted to
compensate for the increase in afterload, with its large
surface area and thin free wall, and this may explain the
rapid hemodynamic compromise and earlier onset of hypo-
tension and shock in patients with predominant RV shock
(18). The lower heart rate in patients with RV shock is likely
related to the lesser degree of LV dysfunction, although
sinus node dysfunction, more vagal tone, or right atrial
stretch may play a role. However, cardiac output and cardiac
index would be expected to be similar for patients with
predominant RV or LV shock once shock ensues.
Angiographic characteristics. Proximal occlusion of the
RCA resulting in anterolateral RV infarction secondary to
occlusion of the acute marginal arteries has been docu-
mented in patients with inferior MI and RV infarction (19).
However, pathologic studies show that the posterior RV
wall (usually in association with LV posterior and postero-
septal infarction) is most frequently involved in RV infarc-
tion, and this is consistent with the observation of RV
infarction after occlusion of a left dominant circumflex
artery or occlusion of the distal RCA (17,20,21). Right
ventricular infarction has been associated with both occlu-
sion of a nondominant RCA and significant RV hypertro-
phy that increases the susceptibility of the RV to ischemia
(22). It is unclear why all proximal RCA occlusions are not
associated with RV infarction, but the lower oxygen require-
ment of the RV, increased coronary blood flow during
systole, increased collateral flow from the left coronary
artery, and diffusion of oxygen from intracavitary blood
through the thin wall of the RV have been implicated (23).
In the present report, it is not surprising that in 96% of
patients with predominant RV shock, the RCA was the
infarct artery. In the 4% of patients with a left main infarct
artery, the left coronary artery likely supplied collateral flow
to a diseased or occluded RCA. It is of interest to note,
however, that RV infarction occurs in less than 10% of
patients with anterior MI. In this setting, RV infarction is
attributed to RV dysfunction caused by LV infarction and
the secondary increase in pulmonary artery pressure and RV
afterload (24), and to compromise of the LAD collateral
flow to the acute marginal arteries. However, an RV current
of injury (ECG ST-segment elevation in V2 to V3) may play
a role in the diagnosis of anterior MI. The absence of the
LAD as the infarct artery in this study supports the latter
hypothesis. The lower prevalence of previous MI in patients
with predominant RV shock is consistent with a lower
prevalence of multivessel disease in comparison with pa-
tients with LV shock.
In-hospital revascularization. The increased use of coro-
nary angioplasty in patients with predominant RV com-
pared with LV shock likely reflects the associated prevalence
of multivessel disease in each group. Similar to the overall
registry (3) and randomized trial (2), revascularization was
associated with lower mortality in both groups. For Registry
patients, this is in part due to a lower risk profile for patients
selected for these treatments. There was no difference in the
impact of revascularization on mortality between patients
with predominant RV or LV shock.
In-hospital mortality. It is generally believed that RV
infarction is associated with a relatively favorable prognosis
(25). However, when inferior MI is complicated by RV
involvement, in-hospital mortality is significantly higher
than in the absence of RV involvement (5), and when RV
infarction results in cardiogenic shock, mortality would be
expected to increase even further. Notwithstanding, it is still
surprising that in this series of patients, mortality for
patients with RV shock was similar to that for patients with
LV shock, which suggests that RV shock defines a partic-
ularly high-risk subset of shock patients. In previous studies
(26,27), mortality rates were lower when RV involvement
was present than when the low cardiac output was due solely
to LV dysfunction.
Clinical implications. Although studies differ concerning
the influence of RV infarction on long-term prognosis, it is
clear that in the majority of survivors, the clinical (and
echocardiographic/radionuclide) (28–30) manifestations of
RV dysfunction return to normal. Optimal management
aimed at support of the RV and reversal of RV ischemia is
essential and currently consists of maintenance of adequate
RV preload with volume loading (although excess volume
further compromises RV function), preservation of RV
synchrony, reduction in RV afterload (particularly when LV
dysfunction is present), and inotropic support of the RV
(31–33). Several studies also suggest a role for early reper-
fusion with fibrinolytic therapy (34,35) or primary angio-
plasty (36,37). Furthermore, early recognition of predomi-
nant RV infarction in the pathogenesis of cardiogenic shock
is critically important to ensure not only that appropriate
treatment is instituted but that therapies that may be
problematic (nitrates, morphine) are avoided. Our study
suggests that in-hospital mortality for patients with pre-
dominant RV shock is unexpectedly high. Strategies to
improve outcome in this subset of patients at high risk are
needed.
Study limitations. These data should be interpreted with
caution, because potentially confounding variables influenc-
ing mortality are not equally distributed between groups in
a registry setting. In addition, the diagnosis of “isolated”
(predominant) RV shock was based on local judgment at
each site and not confirmed centrally. However, RV infarc-
tion is recognized as a clinical syndrome (26,38,39), and
when present, served as an exclusion for entry into the
SHOCK trial. The difference in hemodynamics, infarct
artery, and LV function reported herein lends support to the
accurate diagnosis of RV shock in this Registry.
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